Loading...

Elanco Animal Health Incorporated

ELANNYSE
Healthcare
Drug Manufacturers - Specialty & Generic
$22.75
$0.36(1.63%)
U.S. Market opens in NaNh NaNm

Elanco Animal Health Incorporated (ELAN) Stock Overview

Explore Elanco Animal Health Incorporated’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap11.4B
P/E Ratio-48.45
EPS (TTM)$-0.47
ROE-0.04%
Fundamental Analysis

AI Price Forecasts

1 Month$23.99
3 Months$30.26
1 Year Target$30.54

ELAN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Elanco Animal Health Incorporated (ELAN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 43.12, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $30.54.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -48.45 and a market capitalization of 11.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.59%
5-Day Change
-3.28%
1-Month Change
-8.67%
3-Month Change
-6.80%
6-Month Change
3.13%
Year-to-Date (YTD) Change
0.49%
1-Year Change
140.38%
3-Year Change
123.60%
5-Year Change
-26.65%
All-Time (Max) Change
-36.83%

Contact Information

877 352 6261
2500 Innovation Way, Greenfield, IN, 46140

Company Facts

9,000 Employees
IPO DateSep 20, 2018
CountryUS
Actively Trading

Frequently Asked Questions